Global Neurodegenerative Disease Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neurodegenerative Disease Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Neurodegenerative Disease Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neurodegenerative Disease Treatment market. Neurodegenerative Disease Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurodegenerative Disease Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurodegenerative Disease Treatment market.
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s disease, Parkinson’s disease, ADHD, and ALS, can result in loss of memory and cognitive control. While cures for such conditions are very limited, over the years, the pharmaceutical industry has released a number of treatment offerings to minimize the symptoms of neurodegenerative diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neurodegenerative Disease Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurodegenerative Disease Treatment market. It may include historical data, market segmentation by Type (e.g., Neurotransmitter Agents, Neuroprotective Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurodegenerative Disease Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurodegenerative Disease Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurodegenerative Disease Treatment industry. This include advancements in Neurodegenerative Disease Treatment technology, Neurodegenerative Disease Treatment new entrants, Neurodegenerative Disease Treatment new investment, and other innovations that are shaping the future of Neurodegenerative Disease Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurodegenerative Disease Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Neurodegenerative Disease Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurodegenerative Disease Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurodegenerative Disease Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurodegenerative Disease Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurodegenerative Disease Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurodegenerative Disease Treatment market.
Market Segmentation:
Neurodegenerative Disease Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neurodegenerative Disease Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Neurodegenerative Disease Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neurodegenerative Disease Treatment market. Neurodegenerative Disease Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurodegenerative Disease Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurodegenerative Disease Treatment market.
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s disease, Parkinson’s disease, ADHD, and ALS, can result in loss of memory and cognitive control. While cures for such conditions are very limited, over the years, the pharmaceutical industry has released a number of treatment offerings to minimize the symptoms of neurodegenerative diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neurodegenerative Disease Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurodegenerative Disease Treatment market. It may include historical data, market segmentation by Type (e.g., Neurotransmitter Agents, Neuroprotective Agents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurodegenerative Disease Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurodegenerative Disease Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurodegenerative Disease Treatment industry. This include advancements in Neurodegenerative Disease Treatment technology, Neurodegenerative Disease Treatment new entrants, Neurodegenerative Disease Treatment new investment, and other innovations that are shaping the future of Neurodegenerative Disease Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurodegenerative Disease Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Neurodegenerative Disease Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurodegenerative Disease Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurodegenerative Disease Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurodegenerative Disease Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurodegenerative Disease Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurodegenerative Disease Treatment market.
Market Segmentation:
Neurodegenerative Disease Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Neurotransmitter Agents
- Neuroprotective Agents
- Biologics
- Others
- Multiple Sclerosis [MS]
- Alzheimer’s Disease
- Parkinson's Disease
- Acute Migraine
- Autism
- Narcolepsy
- Amyotrophic Lateral Sclerosis [ALS]
- Attention Deficit Hyperactivity Disorder [ADHD]
- Spinal Muscular Atrophy
- Huntington's Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan plc
- Bayer AG
- F. Hoffmann La-Roche Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck KGaA
- Novartis AG
- Pfizer, Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Treatment Market Size 2019-2030
2.1.2 Neurodegenerative Disease Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurodegenerative Disease Treatment Segment by Type
2.2.1 Neurotransmitter Agents
2.2.2 Neuroprotective Agents
2.2.3 Biologics
2.2.4 Others
2.3 Neurodegenerative Disease Treatment Market Size by Type
2.3.1 Neurodegenerative Disease Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
2.4 Neurodegenerative Disease Treatment Segment by Application
2.4.1 Multiple Sclerosis [MS]
2.4.2 Alzheimer’s Disease
2.4.3 Parkinson's Disease
2.4.4 Acute Migraine
2.4.5 Autism
2.4.6 Narcolepsy
2.4.7 Amyotrophic Lateral Sclerosis [ALS]
2.4.8 Attention Deficit Hyperactivity Disorder [ADHD]
2.4.9 Spinal Muscular Atrophy
2.4.10 Huntington's Disease
2.5 Neurodegenerative Disease Treatment Market Size by Application
2.5.1 Neurodegenerative Disease Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
3 NEURODEGENERATIVE DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Treatment Market Size Market Share by Players
3.1.1 Global Neurodegenerative Disease Treatment Revenue by Players (2019-2024)
3.1.2 Global Neurodegenerative Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE TREATMENT BY REGIONS
4.1 Neurodegenerative Disease Treatment Market Size by Regions (2019-2024)
4.2 Americas Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.3 APAC Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.4 Europe Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Treatment Market Size by Country (2019-2024)
5.2 Americas Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
5.3 Americas Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Treatment Market Size by Region (2019-2024)
6.2 APAC Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
6.3 APAC Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease Treatment by Country (2019-2024)
7.2 Europe Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
7.3 Europe Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease Treatment by Region (2019-2024)
8.2 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE TREATMENT MARKET FORECAST
10.1 Global Neurodegenerative Disease Treatment Forecast by Regions (2025-2030)
10.1.1 Global Neurodegenerative Disease Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Neurodegenerative Disease Treatment Forecast
10.1.3 APAC Neurodegenerative Disease Treatment Forecast
10.1.4 Europe Neurodegenerative Disease Treatment Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Treatment Forecast
10.2 Americas Neurodegenerative Disease Treatment Forecast by Country (2025-2030)
10.2.1 United States Neurodegenerative Disease Treatment Market Forecast
10.2.2 Canada Neurodegenerative Disease Treatment Market Forecast
10.2.3 Mexico Neurodegenerative Disease Treatment Market Forecast
10.2.4 Brazil Neurodegenerative Disease Treatment Market Forecast
10.3 APAC Neurodegenerative Disease Treatment Forecast by Region (2025-2030)
10.3.1 China Neurodegenerative Disease Treatment Market Forecast
10.3.2 Japan Neurodegenerative Disease Treatment Market Forecast
10.3.3 Korea Neurodegenerative Disease Treatment Market Forecast
10.3.4 Southeast Asia Neurodegenerative Disease Treatment Market Forecast
10.3.5 India Neurodegenerative Disease Treatment Market Forecast
10.3.6 Australia Neurodegenerative Disease Treatment Market Forecast
10.4 Europe Neurodegenerative Disease Treatment Forecast by Country (2025-2030)
10.4.1 Germany Neurodegenerative Disease Treatment Market Forecast
10.4.2 France Neurodegenerative Disease Treatment Market Forecast
10.4.3 UK Neurodegenerative Disease Treatment Market Forecast
10.4.4 Italy Neurodegenerative Disease Treatment Market Forecast
10.4.5 Russia Neurodegenerative Disease Treatment Market Forecast
10.5 Middle East & Africa Neurodegenerative Disease Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Neurodegenerative Disease Treatment Market Forecast
10.5.2 South Africa Neurodegenerative Disease Treatment Market Forecast
10.5.3 Israel Neurodegenerative Disease Treatment Market Forecast
10.5.4 Turkey Neurodegenerative Disease Treatment Market Forecast
10.5.5 GCC Countries Neurodegenerative Disease Treatment Market Forecast
10.6 Global Neurodegenerative Disease Treatment Forecast by Type (2025-2030)
10.7 Global Neurodegenerative Disease Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Allergan plc
11.1.1 Allergan plc Company Information
11.1.2 Allergan plc Neurodegenerative Disease Treatment Product Offered
11.1.3 Allergan plc Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Allergan plc Main Business Overview
11.1.5 Allergan plc Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Neurodegenerative Disease Treatment Product Offered
11.2.3 Bayer AG Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 F. Hoffmann La-Roche Ltd.
11.3.1 F. Hoffmann La-Roche Ltd. Company Information
11.3.2 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product Offered
11.3.3 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann La-Roche Ltd. Main Business Overview
11.3.5 F. Hoffmann La-Roche Ltd. Latest Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Information
11.4.2 GlaxoSmithKline plc Neurodegenerative Disease Treatment Product Offered
11.4.3 GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline plc Main Business Overview
11.4.5 GlaxoSmithKline plc Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Neurodegenerative Disease Treatment Product Offered
11.5.3 Johnson & Johnson Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Neurodegenerative Disease Treatment Product Offered
11.6.3 Merck KGaA Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Neurodegenerative Disease Treatment Product Offered
11.7.3 Novartis AG Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Information
11.8.2 Pfizer, Inc. Neurodegenerative Disease Treatment Product Offered
11.8.3 Pfizer, Inc. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer, Inc. Main Business Overview
11.8.5 Pfizer, Inc. Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Neurodegenerative Disease Treatment Product Offered
11.9.3 Sanofi Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
11.10.2 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product Offered
11.10.3 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurodegenerative Disease Treatment Market Size 2019-2030
2.1.2 Neurodegenerative Disease Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurodegenerative Disease Treatment Segment by Type
2.2.1 Neurotransmitter Agents
2.2.2 Neuroprotective Agents
2.2.3 Biologics
2.2.4 Others
2.3 Neurodegenerative Disease Treatment Market Size by Type
2.3.1 Neurodegenerative Disease Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
2.4 Neurodegenerative Disease Treatment Segment by Application
2.4.1 Multiple Sclerosis [MS]
2.4.2 Alzheimer’s Disease
2.4.3 Parkinson's Disease
2.4.4 Acute Migraine
2.4.5 Autism
2.4.6 Narcolepsy
2.4.7 Amyotrophic Lateral Sclerosis [ALS]
2.4.8 Attention Deficit Hyperactivity Disorder [ADHD]
2.4.9 Spinal Muscular Atrophy
2.4.10 Huntington's Disease
2.5 Neurodegenerative Disease Treatment Market Size by Application
2.5.1 Neurodegenerative Disease Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
3 NEURODEGENERATIVE DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Neurodegenerative Disease Treatment Market Size Market Share by Players
3.1.1 Global Neurodegenerative Disease Treatment Revenue by Players (2019-2024)
3.1.2 Global Neurodegenerative Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEURODEGENERATIVE DISEASE TREATMENT BY REGIONS
4.1 Neurodegenerative Disease Treatment Market Size by Regions (2019-2024)
4.2 Americas Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.3 APAC Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.4 Europe Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurodegenerative Disease Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurodegenerative Disease Treatment Market Size by Country (2019-2024)
5.2 Americas Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
5.3 Americas Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurodegenerative Disease Treatment Market Size by Region (2019-2024)
6.2 APAC Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
6.3 APAC Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurodegenerative Disease Treatment by Country (2019-2024)
7.2 Europe Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
7.3 Europe Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurodegenerative Disease Treatment by Region (2019-2024)
8.2 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurodegenerative Disease Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEURODEGENERATIVE DISEASE TREATMENT MARKET FORECAST
10.1 Global Neurodegenerative Disease Treatment Forecast by Regions (2025-2030)
10.1.1 Global Neurodegenerative Disease Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Neurodegenerative Disease Treatment Forecast
10.1.3 APAC Neurodegenerative Disease Treatment Forecast
10.1.4 Europe Neurodegenerative Disease Treatment Forecast
10.1.5 Middle East & Africa Neurodegenerative Disease Treatment Forecast
10.2 Americas Neurodegenerative Disease Treatment Forecast by Country (2025-2030)
10.2.1 United States Neurodegenerative Disease Treatment Market Forecast
10.2.2 Canada Neurodegenerative Disease Treatment Market Forecast
10.2.3 Mexico Neurodegenerative Disease Treatment Market Forecast
10.2.4 Brazil Neurodegenerative Disease Treatment Market Forecast
10.3 APAC Neurodegenerative Disease Treatment Forecast by Region (2025-2030)
10.3.1 China Neurodegenerative Disease Treatment Market Forecast
10.3.2 Japan Neurodegenerative Disease Treatment Market Forecast
10.3.3 Korea Neurodegenerative Disease Treatment Market Forecast
10.3.4 Southeast Asia Neurodegenerative Disease Treatment Market Forecast
10.3.5 India Neurodegenerative Disease Treatment Market Forecast
10.3.6 Australia Neurodegenerative Disease Treatment Market Forecast
10.4 Europe Neurodegenerative Disease Treatment Forecast by Country (2025-2030)
10.4.1 Germany Neurodegenerative Disease Treatment Market Forecast
10.4.2 France Neurodegenerative Disease Treatment Market Forecast
10.4.3 UK Neurodegenerative Disease Treatment Market Forecast
10.4.4 Italy Neurodegenerative Disease Treatment Market Forecast
10.4.5 Russia Neurodegenerative Disease Treatment Market Forecast
10.5 Middle East & Africa Neurodegenerative Disease Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Neurodegenerative Disease Treatment Market Forecast
10.5.2 South Africa Neurodegenerative Disease Treatment Market Forecast
10.5.3 Israel Neurodegenerative Disease Treatment Market Forecast
10.5.4 Turkey Neurodegenerative Disease Treatment Market Forecast
10.5.5 GCC Countries Neurodegenerative Disease Treatment Market Forecast
10.6 Global Neurodegenerative Disease Treatment Forecast by Type (2025-2030)
10.7 Global Neurodegenerative Disease Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Allergan plc
11.1.1 Allergan plc Company Information
11.1.2 Allergan plc Neurodegenerative Disease Treatment Product Offered
11.1.3 Allergan plc Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Allergan plc Main Business Overview
11.1.5 Allergan plc Latest Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Neurodegenerative Disease Treatment Product Offered
11.2.3 Bayer AG Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer AG Main Business Overview
11.2.5 Bayer AG Latest Developments
11.3 F. Hoffmann La-Roche Ltd.
11.3.1 F. Hoffmann La-Roche Ltd. Company Information
11.3.2 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product Offered
11.3.3 F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann La-Roche Ltd. Main Business Overview
11.3.5 F. Hoffmann La-Roche Ltd. Latest Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Information
11.4.2 GlaxoSmithKline plc Neurodegenerative Disease Treatment Product Offered
11.4.3 GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GlaxoSmithKline plc Main Business Overview
11.4.5 GlaxoSmithKline plc Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Neurodegenerative Disease Treatment Product Offered
11.5.3 Johnson & Johnson Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Neurodegenerative Disease Treatment Product Offered
11.6.3 Merck KGaA Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Neurodegenerative Disease Treatment Product Offered
11.7.3 Novartis AG Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Information
11.8.2 Pfizer, Inc. Neurodegenerative Disease Treatment Product Offered
11.8.3 Pfizer, Inc. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer, Inc. Main Business Overview
11.8.5 Pfizer, Inc. Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Neurodegenerative Disease Treatment Product Offered
11.9.3 Sanofi Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
11.10.2 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product Offered
11.10.3 Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurodegenerative Disease Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neurotransmitter Agents
Table 3. Major Players of Neuroprotective Agents
Table 4. Major Players of Biologics
Table 5. Major Players of Others
Table 6. Neurodegenerative Disease Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 9. Neurodegenerative Disease Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Neurodegenerative Disease Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neurodegenerative Disease Treatment Revenue Market Share by Player (2019-2024)
Table 14. Neurodegenerative Disease Treatment Key Players Head office and Products Offered
Table 15. Neurodegenerative Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neurodegenerative Disease Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neurodegenerative Disease Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Neurodegenerative Disease Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neurodegenerative Disease Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neurodegenerative Disease Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neurodegenerative Disease Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Neurodegenerative Disease Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Neurodegenerative Disease Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neurodegenerative Disease Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease Treatment
Table 47. Key Market Challenges & Risks of Neurodegenerative Disease Treatment
Table 48. Key Industry Trends of Neurodegenerative Disease Treatment
Table 49. Global Neurodegenerative Disease Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neurodegenerative Disease Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neurodegenerative Disease Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Allergan plc Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 54. Allergan plc Neurodegenerative Disease Treatment Product Offered
Table 55. Allergan plc Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Allergan plc Main Business
Table 57. Allergan plc Latest Developments
Table 58. Bayer AG Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 59. Bayer AG Neurodegenerative Disease Treatment Product Offered
Table 60. Bayer AG Main Business
Table 61. Bayer AG Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bayer AG Latest Developments
Table 63. F. Hoffmann La-Roche Ltd. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 64. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product Offered
Table 65. F. Hoffmann La-Roche Ltd. Main Business
Table 66. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. F. Hoffmann La-Roche Ltd. Latest Developments
Table 68. GlaxoSmithKline plc Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 69. GlaxoSmithKline plc Neurodegenerative Disease Treatment Product Offered
Table 70. GlaxoSmithKline plc Main Business
Table 71. GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. GlaxoSmithKline plc Latest Developments
Table 73. Johnson & Johnson Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 74. Johnson & Johnson Neurodegenerative Disease Treatment Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Johnson & Johnson Latest Developments
Table 78. Merck KGaA Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 79. Merck KGaA Neurodegenerative Disease Treatment Product Offered
Table 80. Merck KGaA Main Business
Table 81. Merck KGaA Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Merck KGaA Latest Developments
Table 83. Novartis AG Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 84. Novartis AG Neurodegenerative Disease Treatment Product Offered
Table 85. Novartis AG Main Business
Table 86. Novartis AG Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Novartis AG Latest Developments
Table 88. Pfizer, Inc. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 89. Pfizer, Inc. Neurodegenerative Disease Treatment Product Offered
Table 90. Pfizer, Inc. Main Business
Table 91. Pfizer, Inc. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Pfizer, Inc. Latest Developments
Table 93. Sanofi Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 94. Sanofi Neurodegenerative Disease Treatment Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sanofi Latest Developments
Table 98. Teva Pharmaceutical Industries Ltd. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 99. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product Offered
Table 100. Teva Pharmaceutical Industries Ltd. Main Business
Table 101. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 1. Neurodegenerative Disease Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neurotransmitter Agents
Table 3. Major Players of Neuroprotective Agents
Table 4. Major Players of Biologics
Table 5. Major Players of Others
Table 6. Neurodegenerative Disease Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 9. Neurodegenerative Disease Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Neurodegenerative Disease Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Neurodegenerative Disease Treatment Revenue Market Share by Player (2019-2024)
Table 14. Neurodegenerative Disease Treatment Key Players Head office and Products Offered
Table 15. Neurodegenerative Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neurodegenerative Disease Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Neurodegenerative Disease Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Neurodegenerative Disease Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Neurodegenerative Disease Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Neurodegenerative Disease Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Neurodegenerative Disease Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Neurodegenerative Disease Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Neurodegenerative Disease Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Neurodegenerative Disease Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Neurodegenerative Disease Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Neurodegenerative Disease Treatment
Table 47. Key Market Challenges & Risks of Neurodegenerative Disease Treatment
Table 48. Key Industry Trends of Neurodegenerative Disease Treatment
Table 49. Global Neurodegenerative Disease Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Neurodegenerative Disease Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Neurodegenerative Disease Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Allergan plc Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 54. Allergan plc Neurodegenerative Disease Treatment Product Offered
Table 55. Allergan plc Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Allergan plc Main Business
Table 57. Allergan plc Latest Developments
Table 58. Bayer AG Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 59. Bayer AG Neurodegenerative Disease Treatment Product Offered
Table 60. Bayer AG Main Business
Table 61. Bayer AG Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bayer AG Latest Developments
Table 63. F. Hoffmann La-Roche Ltd. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 64. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Product Offered
Table 65. F. Hoffmann La-Roche Ltd. Main Business
Table 66. F. Hoffmann La-Roche Ltd. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. F. Hoffmann La-Roche Ltd. Latest Developments
Table 68. GlaxoSmithKline plc Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 69. GlaxoSmithKline plc Neurodegenerative Disease Treatment Product Offered
Table 70. GlaxoSmithKline plc Main Business
Table 71. GlaxoSmithKline plc Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. GlaxoSmithKline plc Latest Developments
Table 73. Johnson & Johnson Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 74. Johnson & Johnson Neurodegenerative Disease Treatment Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Johnson & Johnson Latest Developments
Table 78. Merck KGaA Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 79. Merck KGaA Neurodegenerative Disease Treatment Product Offered
Table 80. Merck KGaA Main Business
Table 81. Merck KGaA Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Merck KGaA Latest Developments
Table 83. Novartis AG Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 84. Novartis AG Neurodegenerative Disease Treatment Product Offered
Table 85. Novartis AG Main Business
Table 86. Novartis AG Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Novartis AG Latest Developments
Table 88. Pfizer, Inc. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 89. Pfizer, Inc. Neurodegenerative Disease Treatment Product Offered
Table 90. Pfizer, Inc. Main Business
Table 91. Pfizer, Inc. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Pfizer, Inc. Latest Developments
Table 93. Sanofi Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 94. Sanofi Neurodegenerative Disease Treatment Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sanofi Latest Developments
Table 98. Teva Pharmaceutical Industries Ltd. Details, Company Type, Neurodegenerative Disease Treatment Area Served and Its Competitors
Table 99. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Product Offered
Table 100. Teva Pharmaceutical Industries Ltd. Main Business
Table 101. Teva Pharmaceutical Industries Ltd. Neurodegenerative Disease Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Teva Pharmaceutical Industries Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Neurodegenerative Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurodegenerative Disease Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurodegenerative Disease Treatment Sales Market Share by Country/Region (2023)
Figure 8. Neurodegenerative Disease Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurodegenerative Disease Treatment Market Size Market Share by Type in 2023
Figure 10. Neurodegenerative Disease Treatment in Multiple Sclerosis [MS]
Figure 11. Global Neurodegenerative Disease Treatment Market: Multiple Sclerosis [MS] (2019-2024) & ($ Millions)
Figure 12. Neurodegenerative Disease Treatment in Alzheimer’s Disease
Figure 13. Global Neurodegenerative Disease Treatment Market: Alzheimer’s Disease (2019-2024) & ($ Millions)
Figure 14. Neurodegenerative Disease Treatment in Parkinson's Disease
Figure 15. Global Neurodegenerative Disease Treatment Market: Parkinson's Disease (2019-2024) & ($ Millions)
Figure 16. Neurodegenerative Disease Treatment in Acute Migraine
Figure 17. Global Neurodegenerative Disease Treatment Market: Acute Migraine (2019-2024) & ($ Millions)
Figure 18. Neurodegenerative Disease Treatment in Autism
Figure 19. Global Neurodegenerative Disease Treatment Market: Autism (2019-2024) & ($ Millions)
Figure 20. Neurodegenerative Disease Treatment in Narcolepsy
Figure 21. Global Neurodegenerative Disease Treatment Market: Narcolepsy (2019-2024) & ($ Millions)
Figure 22. Neurodegenerative Disease Treatment in Amyotrophic Lateral Sclerosis [ALS]
Figure 23. Global Neurodegenerative Disease Treatment Market: Amyotrophic Lateral Sclerosis [ALS] (2019-2024) & ($ Millions)
Figure 24. Neurodegenerative Disease Treatment in Attention Deficit Hyperactivity Disorder [ADHD]
Figure 25. Global Neurodegenerative Disease Treatment Market: Attention Deficit Hyperactivity Disorder [ADHD] (2019-2024) & ($ Millions)
Figure 26. Neurodegenerative Disease Treatment in Spinal Muscular Atrophy
Figure 27. Global Neurodegenerative Disease Treatment Market: Spinal Muscular Atrophy (2019-2024) & ($ Millions)
Figure 28. Neurodegenerative Disease Treatment in Huntington's Disease
Figure 29. Global Neurodegenerative Disease Treatment Market: Huntington's Disease (2019-2024) & ($ Millions)
Figure 30. Global Neurodegenerative Disease Treatment Market Size Market Share by Application in 2023
Figure 31. Global Neurodegenerative Disease Treatment Revenue Market Share by Player in 2023
Figure 32. Global Neurodegenerative Disease Treatment Market Size Market Share by Regions (2019-2024)
Figure 33. Americas Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 34. APAC Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 35. Europe Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 37. Americas Neurodegenerative Disease Treatment Value Market Share by Country in 2023
Figure 38. United States Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Canada Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 40. Mexico Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. Brazil Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. APAC Neurodegenerative Disease Treatment Market Size Market Share by Region in 2023
Figure 43. APAC Neurodegenerative Disease Treatment Market Size Market Share by Type in 2023
Figure 44. APAC Neurodegenerative Disease Treatment Market Size Market Share by Application in 2023
Figure 45. China Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Japan Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Korea Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. India Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Australia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Europe Neurodegenerative Disease Treatment Market Size Market Share by Country in 2023
Figure 52. Europe Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Figure 53. Europe Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Figure 54. Germany Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. France Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 56. UK Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 57. Italy Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 58. Russia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 59. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Figure 60. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Figure 61. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Figure 62. Egypt Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 63. South Africa Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 64. Israel Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 65. Turkey Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 66. GCC Country Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 67. Americas Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 68. APAC Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Europe Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Middle East & Africa Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 71. United States Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Canada Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Mexico Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Brazil Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 75. China Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Japan Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Korea Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Southeast Asia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 79. India Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Australia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 81. Germany Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 82. France Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 83. UK Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 84. Italy Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 85. Russia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 86. Spain Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 87. Egypt Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 88. South Africa Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 89. Israel Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 90. Turkey Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 91. GCC Countries Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 92. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 93. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neurodegenerative Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurodegenerative Disease Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurodegenerative Disease Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurodegenerative Disease Treatment Sales Market Share by Country/Region (2023)
Figure 8. Neurodegenerative Disease Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurodegenerative Disease Treatment Market Size Market Share by Type in 2023
Figure 10. Neurodegenerative Disease Treatment in Multiple Sclerosis [MS]
Figure 11. Global Neurodegenerative Disease Treatment Market: Multiple Sclerosis [MS] (2019-2024) & ($ Millions)
Figure 12. Neurodegenerative Disease Treatment in Alzheimer’s Disease
Figure 13. Global Neurodegenerative Disease Treatment Market: Alzheimer’s Disease (2019-2024) & ($ Millions)
Figure 14. Neurodegenerative Disease Treatment in Parkinson's Disease
Figure 15. Global Neurodegenerative Disease Treatment Market: Parkinson's Disease (2019-2024) & ($ Millions)
Figure 16. Neurodegenerative Disease Treatment in Acute Migraine
Figure 17. Global Neurodegenerative Disease Treatment Market: Acute Migraine (2019-2024) & ($ Millions)
Figure 18. Neurodegenerative Disease Treatment in Autism
Figure 19. Global Neurodegenerative Disease Treatment Market: Autism (2019-2024) & ($ Millions)
Figure 20. Neurodegenerative Disease Treatment in Narcolepsy
Figure 21. Global Neurodegenerative Disease Treatment Market: Narcolepsy (2019-2024) & ($ Millions)
Figure 22. Neurodegenerative Disease Treatment in Amyotrophic Lateral Sclerosis [ALS]
Figure 23. Global Neurodegenerative Disease Treatment Market: Amyotrophic Lateral Sclerosis [ALS] (2019-2024) & ($ Millions)
Figure 24. Neurodegenerative Disease Treatment in Attention Deficit Hyperactivity Disorder [ADHD]
Figure 25. Global Neurodegenerative Disease Treatment Market: Attention Deficit Hyperactivity Disorder [ADHD] (2019-2024) & ($ Millions)
Figure 26. Neurodegenerative Disease Treatment in Spinal Muscular Atrophy
Figure 27. Global Neurodegenerative Disease Treatment Market: Spinal Muscular Atrophy (2019-2024) & ($ Millions)
Figure 28. Neurodegenerative Disease Treatment in Huntington's Disease
Figure 29. Global Neurodegenerative Disease Treatment Market: Huntington's Disease (2019-2024) & ($ Millions)
Figure 30. Global Neurodegenerative Disease Treatment Market Size Market Share by Application in 2023
Figure 31. Global Neurodegenerative Disease Treatment Revenue Market Share by Player in 2023
Figure 32. Global Neurodegenerative Disease Treatment Market Size Market Share by Regions (2019-2024)
Figure 33. Americas Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 34. APAC Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 35. Europe Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 36. Middle East & Africa Neurodegenerative Disease Treatment Market Size 2019-2024 ($ Millions)
Figure 37. Americas Neurodegenerative Disease Treatment Value Market Share by Country in 2023
Figure 38. United States Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. Canada Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 40. Mexico Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. Brazil Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. APAC Neurodegenerative Disease Treatment Market Size Market Share by Region in 2023
Figure 43. APAC Neurodegenerative Disease Treatment Market Size Market Share by Type in 2023
Figure 44. APAC Neurodegenerative Disease Treatment Market Size Market Share by Application in 2023
Figure 45. China Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. Japan Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Korea Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. India Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Australia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Europe Neurodegenerative Disease Treatment Market Size Market Share by Country in 2023
Figure 52. Europe Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Figure 53. Europe Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Figure 54. Germany Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. France Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 56. UK Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 57. Italy Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 58. Russia Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 59. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Region (2019-2024)
Figure 60. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Type (2019-2024)
Figure 61. Middle East & Africa Neurodegenerative Disease Treatment Market Size Market Share by Application (2019-2024)
Figure 62. Egypt Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 63. South Africa Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 64. Israel Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 65. Turkey Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 66. GCC Country Neurodegenerative Disease Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 67. Americas Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 68. APAC Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Europe Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Middle East & Africa Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 71. United States Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Canada Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Mexico Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Brazil Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 75. China Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Japan Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Korea Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Southeast Asia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 79. India Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Australia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 81. Germany Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 82. France Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 83. UK Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 84. Italy Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 85. Russia Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 86. Spain Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 87. Egypt Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 88. South Africa Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 89. Israel Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 90. Turkey Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 91. GCC Countries Neurodegenerative Disease Treatment Market Size 2025-2030 ($ Millions)
Figure 92. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 93. Global Neurodegenerative Disease Treatment Market Size Market Share Forecast by Application (2025-2030)
